Doxorubicin-induced Id2A gene transcription is targeted at an activating transcription factor/cyclic AMP response element motif through novel mechanisms involving protein kinases distinct from protein kinase C and protein kinase A
about
Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcriptionMolecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytesThe Id2 transcriptional repressor is induced by follicle-stimulating hormone and cAMPPhosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells.Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes.A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes.Profiling of skeletal muscle Ankrd2 protein in human cardiac tissue and neonatal rat cardiomyocytes.Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo.The regulation of β-adrenergic receptor-mediated PKA activation by substrate stiffness via microtubule dynamics in human MSCs.Levels of expression of hRPB11, a core subassembly subunit of human RNA polymerase II, affect doxorubicin sensitivity and cellular differentiation.A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes.An activator of the cAMP/PKA/CREB pathway promotes osteogenesis from human mesenchymal stem cells.
P2860
Q28344911-CD21739B-A260-4752-81AE-05443C6202ABQ28565992-69164B9A-61EC-4ECB-B475-A99E9D78D7E3Q28573683-8BA7AE63-BFF1-488E-A7D7-5F87213C1638Q33707676-D561D40A-FF0E-4A69-B5E0-2922D61FA21CQ34361211-A3610C83-3111-48F9-A502-75888EBFD938Q34437452-CB1D8066-0345-4B72-A603-C2002BF01252Q34458052-AA6BC42E-647B-4E02-8BEA-A3B2E15D566EQ35802653-B8D70C87-706F-4779-AD48-7CF06C6B0BEEQ36663332-65D06947-7ACF-41A6-9DC1-7731B5CB76F9Q38980205-B1CBD17D-6F69-4F6E-93F5-9C93D89E58E3Q41038393-D7919B25-E8AF-4804-B65F-C884D6EF1A9DQ43569485-0A8C064C-FDB2-4044-928D-6EB94E3E5B10Q45877709-514E6798-3946-4791-9F80-0F762BCCCF4D
P2860
Doxorubicin-induced Id2A gene transcription is targeted at an activating transcription factor/cyclic AMP response element motif through novel mechanisms involving protein kinases distinct from protein kinase C and protein kinase A
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@ast
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@en
type
label
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@ast
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@en
prefLabel
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@ast
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@en
P2093
P2860
P356
P1476
Doxorubicin-induced Id2A gene ...... kinase C and protein kinase A
@en
P2093
Jeyaseelan R
Kurabayashi M
P2860
P304
P356
10.1128/MCB.15.11.6386
P407
P577
1995-11-01T00:00:00Z